<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02153606</url>
  </required_header>
  <id_info>
    <org_study_id>Walton-MSA14-GlycerinSupp</org_study_id>
    <nct_id>NCT02153606</nct_id>
  </id_info>
  <brief_title>Glycerin Suppositories Used Prophylactically in Premature Infants (SUPP): a Pilot Randomized Placebo-controlled Trial</brief_title>
  <official_title>Glycerin Suppositories Used Prophylactically in Premature Infants (SUPP): a Pilot Randomized Placebo-controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>McMaster University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>McMaster Surgical Associates</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hamilton Health Sciences Corporation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>McMaster University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      All premature babies have problems with feeding and nutrition. Some can develop a
      life-threatening bowel infection necrotizing enterocolitis. This can result in the need for
      emergency surgery, loss of bowel, lifelong feeding problems, and death. Giving premature
      babies glycerin suppositories may be one way to stimulate the digestive tract and help
      prevent these problems. To see if this treatment works, the investigators need to study
      hundreds of premature babies in a large trial involving multiple hospitals. The purpose of
      this project is to carry out a small study first and make sure that the larger trial is
      feasible. The investigators will invite approximately 30 premature babies from the Neonatal
      Intensive Care Unit at McMaster University Medical Centre to participate in this study over a
      6-month period. The investigators will focus on feasibility issues, including cost, safety,
      and rate of participation. This will allow us to rigorously test our study protocol and lay
      the groundwork for the larger study involving multiple hospitals.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>January 2015</start_date>
  <primary_completion_date type="Anticipated">June 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Days to full enteral feeding (150 ml/kg/day)</measure>
    <time_frame>Up to 4 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Feeding volume on day 14 of life (ml/kg/day)</measure>
    <time_frame>14 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Days to complete meconium evacuation</measure>
    <time_frame>Up to 4 months</time_frame>
    <description>Number of days to complete meconium evacuation (defined as two normal bowel movements free of meconium staining).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Compliance with treatment regimen</measure>
    <time_frame>Up to 4 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Days of parenteral nutrition</measure>
    <time_frame>Up to 4 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Necrotizing enterocolitis</measure>
    <time_frame>Up to 4 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Culture-proven line sepsis</measure>
    <time_frame>Up to 4 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mortality</measure>
    <time_frame>Up to 4 months</time_frame>
  </secondary_outcome>
  <other_outcome>
    <measure>Recruitment rate</measure>
    <time_frame>6 months</time_frame>
    <description>Percentage of eligible infants randomized</description>
  </other_outcome>
  <other_outcome>
    <measure>Completion rate</measure>
    <time_frame>6 months</time_frame>
    <description>Percentage of randomized infants reaching full enteral feeds</description>
  </other_outcome>
  <other_outcome>
    <measure>Treatment-related adverse events</measure>
    <time_frame>Up to 4 months</time_frame>
    <description>Rectal perforation, rectal bleeding, and/or anal fissure</description>
  </other_outcome>
  <other_outcome>
    <measure>Cost</measure>
    <time_frame>6 months</time_frame>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Feeding Intolerance in Premature Infants</condition>
  <arm_group>
    <arm_group_label>Glycerin Suppository</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Sham Suppository</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Glycerin Suppository</intervention_name>
    <description>The treatment intervention will be a 250 mg glycerin suppository placed in the rectum once daily starting 48-72 hours after birth.</description>
    <arm_group_label>Glycerin Suppository</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Sham Suppository</intervention_name>
    <description>Sham suppositories will be created by placing a 250 mg glycerin suppository in the diaper once daily starting 48-72 hours after birth. This intervention works as a non-invasive placebo to maintain blinding.</description>
    <arm_group_label>Sham Suppository</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Gestational age 24-32 weeks OR

          -  Birth weight 500-1500 grams

        Exclusion Criteria:

          -  Congenital gastrointestinal anomalies

          -  Surgery within 48 hours of birth

          -  Culture-proven sepsis*

          -  Vasopressors within 6 hours of first intervention

          -  Nitric oxide

          -  Duct-dependent congenital heart defect requiring prostaglandins

          -  Suspected coagulopathy (mucosal bleeding from any orifice)

          -  Confirmed coagulopathy (any one of the following):

          -  International Normalized Ratio greater than 1.4

          -  Partial Thromboplastin Time greater than 39 seconds

          -  Fibrinogen less than 1.00 grams/liter

          -  Thrombocytopenia (platelet count less than 100 x 10^9/liter)**

          -  Neutropenia (absolute neutrophil count less than 0.5 x 10^9/liter)

          -  Complete meconium evacuation (2 normal bowel movements) within 48 hours of life

          -  Parent or legal guardian unable to understand English

        Note:

        * C-reactive protein is not an exclusion criteria

        ** Indomethacin alone is not an exclusion criteria
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>J M Walton, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>McMaster University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Henrietta Blinder, BSc</last_name>
    <phone>905-521-2100</phone>
    <phone_ext>73507</phone_ext>
    <email>blinderh@mcmaster.ca</email>
  </overall_contact>
  <location>
    <facility>
      <name>McMaster University Medical Centre</name>
      <address>
        <city>Hamilton</city>
        <state>Ontario</state>
        <zip>L8N3Z5</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <link>
    <url>http://fhs.mcmaster.ca/mpsrc/supp_trial.html</url>
    <description>SUPP Trial (McMaster Pediatric Surgery Research Collaborative)</description>
  </link>
  <verification_date>March 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 23, 2014</study_first_submitted>
  <study_first_submitted_qc>May 29, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 3, 2014</study_first_posted>
  <last_update_submitted>March 15, 2016</last_update_submitted>
  <last_update_submitted_qc>March 15, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 17, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Glycerin Suppositories</keyword>
  <keyword>Enteral Nutrition</keyword>
  <keyword>Enterocolitis, Necrotizing</keyword>
  <keyword>Infant, Premature</keyword>
  <keyword>Meconium</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Premature Birth</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Glycerol</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

